Track topics on Twitter Track topics that are important to you
ChemDiv and the German Center for Neurodegenerative Diseases (DZNE) have launched a pre-commercial translational R&D program with support from Torrey Pines Investment.
Janssen and ChemDiv have expanded their multi-year hit identification collaboration to find potent anti-infective drug candidates.
The Tri-Institutional Therapeutics Discovery Institute, Inc. will use ChemDiv's proprietary discovery chemistry platform to advance its research and development (R&D) pipeline.
Research will focus on Sigma1 dysfunction associated with early onset diseases, such as ALS and Alzheimer's
"Tri-I TDI strives to advance groundbreaking academic discoveries to preclinical studies in order to demonstrate their relevance in blocking disease initiation and progression. Our goal at Read m...
ChemDiv Inc. (Chemical Diversity) is a global chemistry-driven contract research organization focused on identifying and delivering discovery opportunities and services for life science partners, ...
ChemDiv, Inc. (ChemDiv) is a global chemistry-driven contract research organization focused on the delivery of new scientific innovation and a range of products and services that meet the drug discove...
We have published hundreds of ChemDiv Inc. news stories on BioPortfolio along with dozens of ChemDiv Inc. Clinical Trials and PubMed Articles about ChemDiv Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ChemDiv Inc. Companies in our database. You can also find out about relevant ChemDiv Inc. Drugs and Medications on this site too.
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...